PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 5, 2026European Journal of General Practice0 citationsOpen Access

Reducing short-acting beta-agonist overprescribing in general practice: Evaluation of a quality improvement programme in East London

View Full Paper
ASAnna De SimoniHHHajar HajmohammadiPPPaul Pfeffer

Key Points

  • The research aims to evaluate a quality improvement programme designed to reduce the overprescribing of short-acting beta-agonists in general practice.
  • Implemented a quality improvement programme in East London practices
  • Provided individual coaching for effective use of electronic tools
  • Utilized integrated prescribing alerts to monitor prescriptions
  • Promoted a culture of collaborative practice for strategy implementation
  • Notable reduction in short-acting beta-agonist overuse
  • Potential decrease in hospital admissions due to lower overprescribing
  • Faster implementation of improvement strategies in supportive practice environments

Abstract

This quality improvement programme was associated with a reduction in SABA overuse, which could also decrease hospital admissions. Practices required individual coaching to use the electronic tools effectively. Integrated prescribing alerts reduced overprescribing, and collaborative practice cultures supported faster implementation of improvement strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Simoni et al. (2026) studied this question.

synapsesocial.com/papers/6984346ff1d9ada3c1fb28achttps://doi.org/10.1080/13814788.2026.2619229
Ask AI
Helpful
Bookmark
Share
View Full Paper